All relevant data are within the paper and its Supporting Information files.

Introduction {#sec006}
============

HIV testing is a critical step in the HIV treatment cascade, which includes diagnosis, linkage to care, engagement in care, initiation of antiretroviral therapy, retention in care, and sustained viral load suppression \[[@pone.0232883.ref001]\]. HIV testing also contributes to the prevention and control of the HIV epidemic in the general population, since people diagnosed with HIV can make decisions that potentially lower their risk of HIV transmission and re-infection, while those who test negative can make informed decisions to protect themselves from getting infected \[[@pone.0232883.ref002]\].

Evidence shows that decision-making and practices related to HIV-testing could be influenced by several factors including accurate knowledge about HIV transmission, perceived risk of HIV infections, attitudes and perceptions of HIV-testing services, and previous history and experiences of HIV-testing \[[@pone.0232883.ref003]\]. HIV testing uptake may also be influenced by individual level factors such as gender, age and marital status, and socio-economic characteristics such as urban or rural residence, education attainment, and employment status among others \[[@pone.0232883.ref003], [@pone.0232883.ref004]\]. Understanding these associations is important for making effective interventions aimed at containing the HIV epidemic, particularly as countries aim to attain the UNADS 90--90--90 targets. These targets are aimed to increase knowledge of HIV‐positive status, initiation of antiretroviral therapy (ART) and viral suppression by 2020 \[[@pone.0232883.ref001], [@pone.0232883.ref005], [@pone.0232883.ref006]\]. Changes in HIV testing overtime has implications for the UNAIDS targets and for evaluating the impact of national policies \[[@pone.0232883.ref007]\].

In South Africa, policy initiatives aligned to meet UNAIDS 90-90-90 targets have an impact on HIV testing \[[@pone.0232883.ref008]\]. The Government has embarked on a deliberate effort to scale up HIV testing services (HTS) by increasing availability of quality HTS and its uptake in all public health facilities \[[@pone.0232883.ref009]\]. Scaling up of HIV testing HIV testing has the potential to affect the first '90' of the UNAIDS 90-90-90 targets.

Due to the high burden of HIV overtime, the country has experienced demographic, socio-economic and behavioural change because of the epidemiological transition \[[@pone.0232883.ref010], [@pone.0232883.ref011]\]. It is therefore important to monitor changes in HIV testing and important indicators in order to inform policy. This study examined temporal trends and factors associated with HIV testing in the South Africa population aged 15 years and older using data from the 2005, 2008, 2012, and 2017 nationally representative population-based household surveys.

Methods {#sec007}
=======

All youth and adults who agreed to participate were required to provide written or verbal (where respondent was illiterate). Written Informed consent for participating in the survey and for the collection of the dried blood spot specimens were obtained or participants 18 years and older. For those less than 18 years informed consent was obtained from parents or guardians and assent obtained from the participants. Where people could not write verbal consent was obtained and fieldwork supervisor signed as witness. The four survey protocols were approved by the Human Sciences Research Council Research Ethics Committee (REC approval numbers: 5/24/06/04; 2/23/10/07; 5/17/11/10 and 4/18/11/15).

Data {#sec008}
----

Data from the 2005, 2008, 2012 and 2017 South African national household-based HIV Prevalence, Incidence and Behaviour surveys were used for this study \[[@pone.0232883.ref012]--[@pone.0232883.ref015]\]. The methodology for these surveys has been the same across the different survey waves, hence allowing this comparison of temporal trends \[[@pone.0232883.ref012]--[@pone.0232883.ref015]\]. The surveys used a multi-stage stratified cluster randomised cross-sectional design. In each survey a systematic probability sample of 15 households was randomly chosen from 1 000 enumeration areas (EAs) which were randomly selected from 86 000 EAs based on the national sampling frame released by Statistics South Africa in 2001 and updated in 2011 \[[@pone.0232883.ref016]--[@pone.0232883.ref018]\]. The sampling of EAs was stratified by province and locality type (urban formal, urban informal, rural formal---including commercial farms and rural informal localities).

Study participants {#sec009}
------------------

In the 2005 and 2008 surveys, in each household a maximum of three people were selected randomly to participate in the study, each representing the 2--14 years, 15--24 years and 25 years and older age groups. In the 2012 and 2017 surveys, all household members were eligible to participate in the survey. In all the surveys age appropriate questionnaires were administered to solicit information on socio-demographic characteristics, sexual practices and behaviour, knowledge, attitudes and perceptions, testing of tuberculosis and HIV, exposure to HIV media campaigns, alcohol and substance use and general health related characteristics. The current analysis focused on individuals aged 15 years and older who responded to the question on ever tested for HIV.

HIV testing {#sec010}
-----------

Dried blood spots' (DBS) specimens were collected from consenting individuals for HIV testing. Samples were tested for HIV using an enzyme immunoassay (EIA) (Vironostika HIV Uni-Form II plus O, Biomeriux, Boxtel, The Netherlands), and samples which tested positive were retested using a second EIA (Advia Centaur XP, Siemens Medical Solutions Diagnostics, Tarrytown, New York, USA). Any samples with discordant results on the first two EIAs were tested with a third EIA (Roche Elecys 2010 HIV Combi, Roche Diagnostics, Mannheim, Germany).

Measures {#sec011}
========

Primary outcome {#sec012}
---------------

In all four surveys, participants who responded to the question "Have you ever been tested for HIV?" are included in the analysis. The response was dichotomized for the primary outcome (yes = 1 and no = 0).

Explanatory variables {#sec013}
---------------------

Covariate socio-demographic variables such as age, grouped into 15--24 years, 25--49 years, 50 years and older, sex (male, female), race (Black Africans, White, Coloured, Indian/Asian), current marital status (not married, married), level of education (no education, primary, secondary, tertiary), employment status (unemployed, employed), and locality type (urban areas, rural informal, rural formal areas) were included.

Other covariates included HIV behavioural variables such as ever had sexual intercourse (no, yes), age of sexual debut (had sex before the age of 15 years, had sex aged 15 years and older), age of sexual partner (partner more than five years younger, partner within five years of age, partner more than five years older), multiple sexual partners in the last 12 months (one partner, two or more partners), condom use at last sex (yes, no), the Alcohol Abuse Disorder Identification Test (AUDIT) score (abstainers, low risk (with scores ranging from1--7), risky/hazardous level (8--15), high risk/harmful (16--19), very high risk (20+), \[[@pone.0232883.ref019]\]. Accurate knowledge about preventing the sexual transmission of HIV was based on responses to five prompted questions; 'Can a person reduce the risk of getting HIV by using a condom every time they have sex?' 'Can a person reduce the risk of HIV by having fewer sexual partners?', 'Can AIDS be cured?' 'Can a person get HIV by sharing food with someone who is infected?' 'Can a healthy-looking person have HIV? Accurate knowledge of preventing the sexual transmission of HIV and rejection of misconceptions about HIV transmission was scored 1 'yes' if all five items were correctly answered, whereas if they answered any incorrectly, they scored 0 'no'. Self-perceived risk of HIV infection (yes, no) and antibody detected HIV status (HIV positive, HIV negative) were also included.

Statistical analysis {#sec014}
====================

Descriptive statistics of socio-demographic variables and HIV risk behaviours by HIV testing were generated for each of the study waves, using frequencies and proportions. P-trend chi-squared test was used to identify any significant change over the four study periods. Percentage differences in HIV testing between the 2005 and 2017 surveys were also calculated. Bivariate logistic regression analysis was used to assess factors associated with having ever been tested for HIV for each study wave. All statistically significant variables were entered into a final multivariate logistic regression model. Crude Odds ratios (OR) and adjusted (aOR) for the bivariate and multivariate models, with 95% Confidence intervals (CI) and a p-value ≤ 0.05 were considered statistically significant. Separate models were fitted for each of the survey waves. Sample weights were introduced to all models to account for the complex survey design and non-response using the 'svy' command. Statistical analyses were done using Stata statistical software, Release 15.0 (College Station, TX: Stata Corporation).

Results {#sec015}
=======

Trends in ever having tested for HIV in 2005--2017 {#sec016}
--------------------------------------------------

[Table 1](#pone.0232883.t001){ref-type="table"} shows trends in ever having tested for HIV by socio-demographic characteristics among youth and adults aged 15 years and older. Overall the percentage of those ever been tested for HIV increased from 30.6% in 2005 to 75.2% in 2017 (a 44.6% point increase). There was a significant increase in the percentages of respondents who had ever been tested for HIV across all socio-demographic characteristics from 2005 to 2017 (p\<0.001 for all variables). The largest increase was among those aged 50 and older changing from 18.3% in 2005 to 69.7% in 2017 (a 51.4% point increase), Black Africans from 26.2% in 2005 to 76.5% in 2017 (a 50.3% point increase), those with no education or who had only attained primary school education from 18.4% in 2005 to 71.9% in 2017 (a 53.5% point increase), those unemployed from 23.2% in 2005 to 70.7% in 2017 (a 47.5% point increase), and those residing in rural informal areas from 19.4% to 70.3% in 2017 (a 50.9% point increase).

10.1371/journal.pone.0232883.t001

###### Trend in ever having tested for HIV by socio-demographic characteristics of the study participants age 15 years and older in South Africa by survey period from 2005--2017.

![](pone.0232883.t001){#pone.0232883.t001g}

                           2005     2008   2012         2017                                                                                          
  ------------------------ -------- ------ ------------ -------- ------ ------------ -------- ------ ------------ -------- ------ ------------ ------ ---------
  **Age categories**                                                                                                                                  
  Total                    16 112   30.6   29.1--32.1   13 084   50.4   48.9--51.8   26 381   65.5   64.2--66.7   23 190   75.2   74.0--76.4   44.6   \<0.001
  15--24 years             5 615    19.3   17.7--20.9   4 192    37.3   35.1--39.6   7 121    50.6   48.5--52.7   5 921    58.8   56.6--61.1   39.5   \<0.001
  25--49 years             6 764    43.1   40.8--45.5   5 606    65.1   63.0--67.2   11 553   78.2   76.6--79.8   10 674   85.0   83.6--86.2   41.9   \<0.001
  50+ years                3 733    18.3   16.4--20.4   3 286    34.1   31.6--36.6   7 707    54.8   52.7--57.0   6 595    69.7   68.0--71.4   51.4   \<0.001
  **Sex of respondent**                                                                                                                               
  Male                     6 193    27.6   25.5--29.8   5 193    44.2   42.0--46.4   11 403   59.0   57.2--60.8   9 762    70.9   69.2--72.5   43.3   \<0.001
  Female                   9 919    33.0   31.3--34.7   7891     55.8   54.1--57.4   14 978   71.5   70.1--72.9   13 428   79.3   78.0--80.5   46.3   \<0.001
  **Race of respondent**                                                                                                                              
  Black African            9 515    26.2   24.6--27.8   7 844    49.0   47.3--50.7   15 166   65.8   64.3--67.2   15 255   76.5   75.1--77.9   50.3   \<0.001
  White                    1 888    53.2   48.5--57.9   1 570    59.0   55.4--62.5   2 823    62.7   58.8--66.4   1 634    69.4   65.9--72.8   16.2   \<0.001
  Coloured                 2 949    36.2   33.1--39.4   2 348    51.0   48.1--54.0   4 911    67.8   65.4--70.1   4 182    73.8   71.7--75.7   37.6   \<0.001
  Indian/Asian             1 728    44.7   39.6--49.8   1 294    51.6   46.0--57.2   3 419    60.6   55.7--65.3   2 119    61.8   56.7--66.7   17.1   \<0.001
  **Marital status**                                                                                                                                  
  Not married              10 160   25.5   24.0--27.1   8 392    47.4   45.6--49.1   16 707   62.4   60.8--64.0   7 391    81.1   79.6--82.6   55.6   \<0.001
  Married                  5 917    39.1   36.6--41.8   4 649    56.1   53.8--58.4   9 276    73.2   71.3--75.0   15 794   72.8   71.4--74.2   33.7   \<0.001
  **Level of education**                                                                                                                              
  No education/Primary     4 537    18.4   16.4--20.5   3 291    35.8   33.4--38.3   4 285    58.4   56.0--60.7   3 626    71.9   69.8--74.0   53.5   \<0.001
  Secondary                9 955    31.7   29.9--33.5   8 384    52.3   50.5--54.1   15 883   66.2   64.6--67.8   11 266   80.4   79.0--81.7   48.7   \<0.001
  Tertiary                 1 571    61.4   57.6--65.1   1 330    72.7   68.7--76.4   2 248    81.8   78.2--84.8   2 471    85.2   82.9--87.3   23.8   \<0.001
  **Employment status**                                                                                                                               
  Unemployed               10 822   23.2   21.9--24.7   8 163    43.3   41.8--44.9   14 298   61.3   59.7--62.9   14 796   70.7   69.2--72.0   47.5   \<0.001
  Employed                 5 223    46.0   43.0--49.1   4 854    62.3   59.8--64.7   9 658    75.2   73.2--77.0   8 070    83.7   82.1--85.2   37.7   \<0.001
  **Locality type**                                                                                                                                   
  Urban areas              11 011   38.9   36.9--40.9   9 370    53.7   51.9--55.5   18 271   68.0   66.4--69.6   15 082   77.4   76.0--78.7   38.5   \<0.001
  Rural informal areas     3 682    19.4   17.3--21.5   2 837    43.1   40.6--45.6   5 602    61.6   59.6--63.5   5 432    70.3   68.0--72.4   50.9   \<0.001
  Rural formal areas       1 419    21.0   16.7--26.1   877      50.4   45.6--55.1   2 508    63.0   57.4--68.2   2 676    71.2   67.2--74.9   50.2   \<0.001

\* p-value ≤ 0.05 was considered statistically significant

[Table 2](#pone.0232883.t002){ref-type="table"} shows trends in ever having tested for HIV by risk behaviour characteristics among youth and adults aged 15 years and older. There was a significant increase in the percentages of respondents who had ever been tested for HIV across all HIV risk behaviour characteristics in 2005 to 2017 (p\<0.001 for all variables). The largest increase was among those who ever had sex from 34.6% in 2005 to 81.1% in 2017 (a 46.5% point increase), those with sexual partners 5 years and older than themselves, from 29.7% in 2005 to 89.9% in 2017 (a 60.2% point increase), those with two or more sexual partners from 35.5% in 2005 to 83.0% in 2017 (a 47.5% point increase), among those who reported no alcohol consumption from 27.0% in 2005 to 73.6 in 2017 (a 46.6% point increase) and among those who tested HIV positive in the survey, from 36.7% in 2005 to 87.1% in 2017 (a 50.4% point increase).

10.1371/journal.pone.0232883.t002

###### Trend in every having tested for HIV by HIV risk behaviour characteristics of the study participants age 15 years and older in South Africa by survey period from 2005--2017.
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                                                        2005     2008   2012         2017                                                                                          
  ----------------------------------------------------- -------- ------ ------------ -------- ------ ------------ -------- ------ ------------ -------- ------ ------------ ------ ---------
  **Sexual activity**                                                                                                                                                              
  Never had sex                                         2 596    8.3    6.4--10.6    1 910    15.8   13.3--18.7   3 317    28.4   25.6--31.4   3 655    43.4   40.5--46.3   35.1   \<0.001
  Had sex                                               13 148   34.6   33.0--36.3   9 586    55.2   53.7--56.8   22 360   71.0   69.7--72.3   18 319   81.1   80.0--82.2   46.5   \<0.001
  **Sexual debut**                                                                                                                                                                 
  Sex before aged 15                                    248      25.4   19.0--32.9   192      44.5   34.9--54.4   391      57.9   50.3--65.2   387      66.1   59.6--72.0   40.7   \<0.001
  Sex at aged 15 and older                              5 367    19.0   17.3--20.7   3 911    36.8   34.5--39.2   6 696    50.0   47.9--52.2   5 513    58.1   55.8--60.4   39.1   \<0.001
  **Age of sexual partner**                                                                                                                                                        
  Partner more than 5 years younger                     1 624    36.2   32.6--40.1   1 138    52.1   47.5--56.6   2 659    72.8   69.7--75.7   2 21     81.6   79.1--83.9   45.4   \<0.001
  Partner within five years                             5 329    39.4   36.9--42.1   3 997    60.1   57.8--62.4   9 739    73.2   71.4--74.9   6 874    84.1   82.7--85.5   44.7   \<0.001
  Partner more than 5 years older                       5 943    29.7   27.8--31.8   1 448    65.9   62.2--69.5   3 241    86.3   84.3--88.1   2 728    89.9   88.3--91.3   60.2   \<0.001
  **Number of sexual partners in the past 12 months**                                                                                                                              
  1 sexual partner                                      8 444    39.5   37.5--41.6   648      47.8   41.8--54.0   14 183   77.0   75.7--78.3   10 845   84.9   83.8--86.0   45.4   \<0.001
  2 or more sexual partners                             674      35.5   29.6--41.8   7 159    61.8   60.0--63.6   1 487    67.8   64.0--71.4   1 049    83     79.8--85.9   47.5   \<0.001
  **Condom use at last sex in the past 12 months**                                                                                                                                 
  No condom use                                         6 215    39.7   37.3--42.2   4 900    59.9   57.5--62.1   10 663   75.7   74.0--77.4   7 657    84.6   83.2--85.9   44.9   \<0.001
  Yes condom use                                        2 961    38.2   35.5--41.0   2 887    61.0   58.4--63.6   4 707    76.0   73.9--78.0   4 144    85     83.4--86.4   46.8   \<0.001
  **AUDIT Score**                                                                                                                                                                  
  Abstainers                                            10 979   27.0   25.4--28.6   8 892    48.0   46.4--49.7   14 638   64.3   62.8--65.8   15 168   73.6   72.0--75.1   46.6   \<0.001
  Low risk (1--7)                                       2 905    39.4   36.3--42.6   2 826    59.6   56.7--62.5   6 326    68.3   65.8--70.6   4 067    77.6   75.5--79.6   38.2   \<0.001
  Risky/hazardous level (8--15)                         805      36.5   31.4--41.9   936      47.3   42.1--52.5   1 855    63.9   59.7--67.8   1 473    79.9   76.4--82.9   43.4   \<0.001
  High risk/harmful (16--19)                            143      33.4   24.5--43.6   120      37.4   25.2--51.4   340      62.1   53.6--70.0   253      75.7   66.7--83.0   42.3   \<0.001
  High risk (20+)                                       1 124    38.6   34.3--43.0   128      50.2   37.4--63.1   295      65.7   56.3--73.9   263      71.5   62.5--79.0   32.9   \<0.001
  **Correct HIV knowledge and myth rejection**                                                                                                                                     
  No knowledge                                          9 184    28.4   26.7--30.2   8 902    48.3   46.7--49.9   18 716   64.4   62.9--65.8   14 652   74.1   72.7--75.4   45.7   \<0.001
  Yes knowledge                                         6 904    33.4   31.3--35.6   4 138    55.0   52.4--57.4   7 555    68.9   67.0--70.7   8 492    77.3   75.7--78.9   43.9   \<0.001
  **Self--perceived risk of HIV infection**                                                                                                                                        
  No risk                                               11 151   28.6   26.8--30.5   10 081   48.0   46.3--49.6   4 904    75.1   73.1--77.1   18 383   72.3   70.9--73.7   43.7   \<0.001
  Yes risk                                              4 914    34.1   31.9--36.3   2 923    56.2   53.7--58.8   21 240   62.3   60.8--63.8   2 836    79.3   76.8--81.5   45.2   \<0.001
  **HIV status**                                                                                                                                                                   
  HIV Negative                                          10 510   29.3   27.6--31.0   8 929    48.2   46.5--49.8   17 872   62.3   60.8--63.8   13 193   74.7   73.4--75.9   45.4   \<0.001
  HIV Positive                                          1 328    36.7   32.9--40.7   1 227    65.2   61.2--69.0   2 605    81.7   79.2--84.0   2 604    87.1   84.7--89.2   50.4   \<0.001

\* p-value ≤ 0.05 was considered statistically significant

Determinants of ever having tested for HIV in 2005--2017 {#sec017}
--------------------------------------------------------

All variables in the bivariate logistic regression analysis were statistically significant and therefore they were all controlled for in the multivariate logistic regression analysis. [Fig 1](#pone.0232883.g001){ref-type="fig"} shows coefficient plots of the final multiple logistic regression models of determinants of ever being tested for HIV in each survey wave. The increased likelihood of ever being tested for HIV was significantly associated with those aged 25--49 years rather than those aged 15--24 years, in 2005 \[aOR = 1.33 (95% CI: 1.06--1.66), p = 0.013\], 2008 \[aOR = 2.08 (95% CI: 1.75--2.47), p\<0.001\], 2012 \[aOR = 2.5 (95% CI: 2.1--3.0) p\<0.001\], and 2017 \[aOR = 2.5 (95% CI: 2.1--3.0), p\<0.001\]. Females were significantly more likely to have ever tested for HIV than males, in 2005 \[aOR = 1.74 (95% CI: 1.44--2.10), p\<0.001\], 2008 \[aOR = 1.83 (95% CI: 1.59--2.11), p\<0.001\], 2012 \[aOR = 2.3 (95% CI: 2.0--2.6), p\<0.001\], and 2017 \[aOR = 2.05 (95% CI: 1.88--2.23), p\<0.001\]. Whites were significantly more likely to have ever tested for HIV than Black Africans, in 2005 \[aOR = 2.64 (95% CI: 1.99--3.49), p\<0.001\] and in 2008 \[aOR = 1.31 (95% CI: 1.02--1.68), p = 0.031\]. Similarly, Indians \[aOR = 1.57 (95% CI: 1.2--2.1), p\<0.001\], and Coloureds \[aOR = 1.61 (95% CI: 1.3--2.0), p\<0.001\], were significantly more likely to ever have tested for HIV in 2005 than Black Africans. Married respondents were significantly more likely to have ever tested for HIV than those unmarried: in 2005 \[aOR = 1.24 (95% CI: 1.04--1.47), p = 0.018\], in 2008 \[aOR = 1.23 (95% CI: 1.06--1.44), p = 0.008\], in 2012 \[aOR = 1.60 (95% CI: 1.3--1.9), p\<0.001\], and in 2017 \[aOR = 1.58 (95% CI: 1.41--1.76), p\<0.001\].

![Multivariate logistic regression models of determinates of having ever been tested for HIV in South Africa by survey period from 2005--2017.](pone.0232883.g001){#pone.0232883.g001}

The increased likelihood of ever being tested for HIV was also significantly associated with attainment of a secondary school level of education compared to those who had no education or those who only had attained primary school education, in 2005 \[aOR = 1.56 (95% CI:1.26--1.93, p\<0.001\], 2008 \[aOR = 1.80 (95% CI:1.52--2.12), p\<0.001\], 2012 \[aOR = 1.5 (95% CI:1.3--1.7), p\<0.001\], and 2017 \[aOR = 1.76 (95% CI: 1.58--1.96), p\<0.001\]. Tertiary level education had higher likelihood of ever being tested for HIV, in 2005 \[aOR = 3.74 (95% CI:2.74--5.12), p\<0.001\], 2008 \[aOR = 3.74 (95% CI:2.74--5.11), p\<0.001\], 2012 \[aOR = 2.7 (95% CI:1.9--4.0), p\<0.001\], and 2017 \[aOR = 2.66 (95% CI:2.21--3.20), p\<0.001\] compared to the same referent. Employed respondents were significantly more likely to have ever tested for HIV than those not employed, in 2005 \[aOR = 1.50 (95% CI: 1.27--1.78), p\<0.001\], 2008 \[aOR = 1.55 (95% CI: 1.30--1.83), p\<0.001\], 2012 \[aOR = 1.3 (95% CI: 1.2--1.5), p\<0.001\], and 2017 \[aOR = 1.34 (95% CI: 1.22--1.48, p\<0.001\]. Those with accurate knowledge of preventing the sexual transmission of HIV and rejection of misconceptions about HIV transmission were significantly more likely to have ever tested for HIV, in 2005 \[aOR = 1.17 (95% CI: 1.00--1.36), p = 0.052\], 2012 \[aOR = 1.2 (95% CI: 1.1--1.4), p = 0.006\], and 2017\[aOR = 1.15 (95% CI: 1.05--1.25), p = 0.002\]. The respondents who perceived themselves as being at risk of HIV infection were significantly more likely to have ever tested for HIV, in 2005 \[aOR = 1.23 (95% CI: 1.05--1.44), p = 0.009\], 2008 \[aOR = 1.30 (95% CI: 1.10--1.52), p = 0.002\], and 2017 \[aOR = 1.40 (95% CI: 1.24--1.57), p\<0.001\], except in 2012 \[aOR = 0.7 (95% CI: 0.6--0.8), p\<0.001\]. Those who tested HIV positive were significantly more likely to have ever tested for HIV, in 2005 \[aOR = 1.27 (95% CI: 1.03--1.57), p = 0.027\], 2008 \[aOR = 1.57 (95% CI: 1.27--1.94), p\<0.001\], and 2012 \[aOR = 1.7 (95% CI: 1.4--2.0), p\<0.001\], and in 2017 \[aOR = 1.28 (95% CI: 1.13--1.54), p\<0.001\].

The decreased likelihood of being tested for HIV was significantly associated with those aged 50 years and older years than those aged 15--24 years, in 2005 \[aOR = 0.43 (95% CI: 0.34--0.56), p\<0.001\], and 2008\[aOR = 0.70 (95% CI: 0.57--0.86), p\<0.001\]. The decreased likelihood of ever having tested for HIV was significantly associated with being white in 2012 \[aOR = 0.7 (95% CI: 0.6--0.9), p = 0.011\], and 2017 \[aOR = 0.49 (95% CI: 0.40--0.61), p\<0.001\] than Black Africans. In 2012, Indians/Asians were significantly less likely to ever have tested for HIV than Black Africans \[aOR = 0.34 (95% CI: 0.28--0.40), p\<0.001\] and in 2017 \[aOR = 0.34 (95% CI: 0.28--0.40), p\<0.001\]. Coloureds were significantly less likely to ever have tested for HIV than Black Africans in 2017 \[aOR = 0.81 (95% CI: 0.71--0.92), p\<0.001\]. Those residing in rural informal areas were significantly less likely to have ever have tested for HIV in 2005 \[aOR = 0.63(95% CI: 0.51--0.78), p\<0.001\], and 2017 \[aOR = 0.80 (95% CI: 0.73--0.89), p\<0.001\] including those residing in rural formal areas in 2017 \[aOR = 0.70 (95% CI: 0.61--0.79), p\<0.001\] compared to respondents from urban areas.

Discussion {#sec018}
==========

This study reports results on HIV testing trends for those who have ever tested across four nationally representative surveys in the South African population aged 15 years and older.

The observed overall significant increase in youth and adults 15 years and older who have ever been tested for HIV is encouraging, especially among Black Africans. This suggests that the national HIV testing programmes are gradually reaching these two groups that are still the most vulnerable to HIV infection. There is also an indication that over time (between the study waves) the national HTS programme is reaching high-risk groups, especially those who are sexually active, those with older sexual partners and those who tested positive in the survey rounds. Scaling up access and outreach to testing among most at risk populations remains an important goal for universal access to treatment and support in South Africa \[[@pone.0232883.ref020]\].

Understanding the associations between ever having tested for HIV and these identified factors may help improve HIV testing policy and increase testing utilization, which together will lead to better control of the HIV epidemic in South Africa. The current findings revealed that over the past decade people aged 25--49 years were more likely to test for HIV than people aged 15--24 years. These findings are similar to the findings from other studies \[[@pone.0232883.ref021], [@pone.0232883.ref022]\]. This is not surprising, as older people would have had more opportunities to have ever tested compared to those who are younger. What is concerning is that younger people represent the largest proportion of new HIV cases in South Africa \[[@pone.0232883.ref015]\]. Providing increased access to HIV testing in educational settings will increase awareness of HIV status among the youth \[[@pone.0232883.ref023]\]. Studies have also shown that by including youth in the planning and development of HIV testing strategies and by providing youth friendly environments for HIV testing, increases the uptake of HIV testing in this age group \[[@pone.0232883.ref023], [@pone.0232883.ref024]\].

The findings also show that the proportion of people who have ever tested for HIV was lower among those residing in rural areas compared to residing in urban areas \[[@pone.0232883.ref025]\]. This could reflect poor programme outreach in rural areas due to the focus on urban areas as a result of the high prevalence of HIV in the urban areas. This disparity in service delivery is well documented in other studies \[[@pone.0232883.ref026]\]. There is need to expand services in rural areas in order to increase access to testing services for the rural population. Community-based approaches such as mobile health clinics and door-to-door campaigns have been shown to be successful in reaching populations that do not present at health facilities and where there are inadequate fixed facilities to provide HIV testing services \[[@pone.0232883.ref027]--[@pone.0232883.ref029]\].

The findings showed that HIV testing has increased substantially among Black Africans. This may be due to the targeted and/or focussed national testing efforts. This may reflect the success of the national HIV testing and counselling campaign launched in 2010, and the revitalised HIV testing services which focused on getting more people to test for HIV \[[@pone.0232883.ref008], [@pone.0232883.ref020]\]. However, there is a growing concern with regard to the Coloured race group, as there seems to be a brewing HIV epidemic among this population \[[@pone.0232883.ref015]\]. The changing racial dynamics over time suggest that efforts to get people to test have been uneven and need to be addressed. HIV testing services therefore need to be inclusive to prevent the oversight of other racial groups in providing this critical service across the board \[[@pone.0232883.ref030]\]. The proportion of Whites and Indian/Asians ever having tested for HIV increased like every other race group but not to the same extent, a 16.2% and 17.1% point increase respectively as compared to a 37.6% point increase for Coloureds and a 50.3% point increase for Black Africans. Previous research shows that other race groups are often reluctant to test, as they perceive themselves as not being at risk of HIV \[[@pone.0232883.ref014], [@pone.0232883.ref015]\].

In addition, the findings showed that marriage, education, and employment is associated with an increase in HIV testing. This is similar to other studies \[[@pone.0232883.ref031]--[@pone.0232883.ref033]\]. In South Africa, associations have also been shown between an individual's socio-economic background and the likelihood to test for HIV \[[@pone.0232883.ref014], [@pone.0232883.ref015]\]. The findings indicate that there is a need to target people with no or little formal education and those not employed.

These findings also showed that those who tested positive in the survey rounds were more like to have tested for HIV. This is encouraging as awareness of HIV status among those who are HIV positive is essential to ensure that people living with HIV are supported and receive treatment.

Limitations {#sec019}
===========

Some key limitations for our study include that data on HIV testing, socio-demographic and HIV related risk behaviours were collected using self-reports, and so were subject to social desirability and recall biases. Furthermore, each survey wave was cross-sectional in nature rather than longitudinal. The study is therefore limited to assessing the associations between HIV testing and potential determinants as one cannot infer causality among the variables studied. Nevertheless, the study provides nationally representative data on trends in ever testing for HIV that can be inferred to the general youth and adult population in South Africa.

Conclusion {#sec020}
==========

It is encouraging that HIV testing uptake has increased significantly from 2005 to 2017 in South Africa. HIV testing programmes have reached those most at risk of HIV infection. However, more HIV testing opportunities in different settings that prompts both provider and client initiated approaches are required to ensure that low HIV testing groups are reached. The findings inform the need for a comprehensive strategy targeting young people, those living in rural areas, the never married, those with no formal education or low educational attainment, and the unemployed. [Box 1](#sec021){ref-type="sec"} outline key challenges identified and recommendations for improving HIV testing.

Box 1. Key challenges to HIV testing and policy recommendations. {#sec021}
----------------------------------------------------------------

Supporting information {#sec022}
======================

###### 

(ZIP)

###### 

Click here for additional data file.
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Please include in your financial disclosure statement the name of the funders of this study (as well as grant numbers if available). At present, this information is only available in your acknowledgement section.

Response: Financial disclosure has now been moved from acknowledgements to the Funding Statement.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

\'The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\'

a\. Please provide an amended Funding Statement that declares \*all\* the funding or sources of support received during this specific study (whether external or internal to your organization) as detailed online in our guide for authors at <http://journals.plos.org/plosone/s/submit-now>

b\. Please state what role the funders took in the study. If any authors received a salary from any of your funders, please state which authors and which funder. If the funders had no role, please state: \"The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\"
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5\. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.
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5\. Review Comments to the Author

Introduction: In paragraph two the authors present a very generic discussion around barriers to testing and linkage to care. They further discuss that, "Although some studies found that individual factors affect uptake of HIV testing, some found mixed results that included factors relating to community, society and relationships' type" This argument and sentence feels somewhat mis-placed since statics cross sectional population based surveys are unlikely to provide the depth to understand these associations.

Response: The line has been deleted and paragraph revised, see line 86-96.

What is missing and necessary is two things:

1\. How has health policy around HIV testing, and LTC changed in South Africa for the last fifteen years - these authors are experts and should be able to pain the picture.

Response: This is now captured in a new paragraph in lines 94-98.

2\. What is the benefit of this type of longitudinal analysis, has these been done elsewhere , has it changed policy, why did the authors write this paper?

Response: This is now captured in a new paragraph in lines 99-102.

Methods: Nil to add, well written and thorough

Results:

Table 1 and 2, are necessary and complete

Couple of comments:

1\. The paragraphs under determinants of health is extremely dense and difficult to read and thus asorb. May be the authors should draw a conceptual model with the demographic and behavioral factors tested, with some color distinction for those with stronger associations and those with weaker associations. This would be more meaningful, than the paragraphs written.

Response: Unfortunately most readers would like to see results in the text and would like to keep them.

2\. While I like figure 1, it is too much data for the reader to absorb, also the figure need s to be edited -- font/spacing etc so that it is more readable on a web-based platform.

Response: The figure has been greatly improved, and has been put through PACE.

3\. I would love to see a graphical representation of the care cascade over time, I would also like to see and interrupted time-series analysis that high lights temporal impact of national policy roles outs and on the subsequent household survey. This should be before tables 1 and 2, and should show the big picture.

Response: The focus of this analysis was not on the care cascade but rather on HIV testing overtime as it affects the UNAIDS indicators, especially the first 90. Besides there is no data on temporal impact of national policy roles outs and on the subsequent household survey.

Discussion:

While the discussion is well written it could be further strengthened. The authors are presenting really rich data, and so should end the discussion with key policy recommendations. Maybe this is a summary box, that ties together the key findings from each paragraph.

Response: Key challenges and recommendations are now included, see lines 355-364

Reviewer \#2: This manuscript is well written and provides a descriptive analysis of trends and associations in ever HIV testing in South Africa.

Introduction

The introduction provides a sound rational for the study/analysis questions. The authors describe the multiple layers (individual, social, and structural) that influence HIV testing. Would consider grounding it in the eco-social framework for HIV transmission (Baral et al BMC Public Health 2013).

Response: Revised, see line 86-98

Methods

The methodology was well described, however it would be helpful to have additional information on the adjustments made for the complex survey analysis, and how missing data was handled.

Response: Sample weights were introduced to all models account for the complex survey design and non-response using the 'svy' command, see lines 181-183.

The authors described DBS for HIV testing, but these results were not presented in the manuscript. If they were not used in the analysis, then I would limit the description of the HIV testing to a procedure that was done as part of the survey, but data from testing was not presented.

Response: Antibody detected HIV status (HIV positive, HIV negative) was included in the analysis as covariate, see line 170.

Results

The results were well described and the tables were easy to read.

For the multivariate analysis, all the odds ratios should be adjusted odds ratios given that there were multiple variables used for adjustment.

Response: Corrected as suggested.

Minor point - there should be a space between 95% CI, it\'s missing for several lines in this part of the results.

Response: Corrected as suggested.

Figure 1 is very blurry. It would also be helpful to included \"Education\" for \"Secondary\" and \"Tertiary\" for the model.

Response: The figure has been greatly improved as suggested. The figure has been put through PACE.
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2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.
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